Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

HGS's KGF-2 enters clinical testing

Feb. 13, 1998

Promising results with AlloDerm reported

Feb. 10, 1998

Celtrix and Genzyme expand collaboration

Feb. 10, 1998

Psovascar enters phase I/II for psoriasis

Feb. 9, 1998

P&U receives three-year marketing exclusivity for Rogaine Extra Strength

Feb. 6, 1998

Avita gel can now be launched in U.S.

Feb. 5, 1998

ProCyte reports results from U.K. leg ulcer study

Feb. 5, 1998

Promising preclinical results reported for Resolve

Feb. 4, 1998

PB-005 studied in postsurgical wound healing

Feb. 3, 1998

FDA advisory panel recommends Apligraf

Feb. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...